Rx Propellant plans Rs 1,100-crore lab in Hyderabad
indiatimes.com
science
2022-10-19 19:45:00

AFPRX Propellant has already invested Rs 900 crore in the development of its existing life-sciences infrastructure and is planning to invest another Rs2,000 crore to build more than 10 million sq ft of lab space over the next five years across Hyderabad, Bengaluru and Navi Mumbai.Rx Propellant has deployed Rs 1,100 crore, its first from $200 million that global fund Actis infused in the life-sciences real estate development platform, to develop a lab space at Genome Valley in Hyderabad. At Genome Valley, the company plans to develop a 9,00,000 square feet lab space, to be operational over mid-2025.
